-
1
-
-
0003187521
-
European Commission. European Commission Regulation (EC) No 141/2000 of the European Parliament and the Council of 16 December 1999 on orphan medicinal products
-
L
-
European Commission. European Commission Regulation (EC) No 141/2000 of the European Parliament and the Council of 16 December 1999 on orphan medicinal products. Official Journal of the European Communities 2000, L18(1).
-
(2000)
Official Journal of the European Communities
, vol.18
, Issue.1
-
-
-
3
-
-
77953336048
-
-
Belgian Health Care Knowledge Centre, Brussels
-
Denis A., Simoens S., Fostier C., Mergaert L., Cleemput I. Health technology assessment policy governing rare diseases and orphan medicines 2009, Belgian Health Care Knowledge Centre, Brussels.
-
(2009)
Health technology assessment policy governing rare diseases and orphan medicines
-
-
Denis, A.1
Simoens, S.2
Fostier, C.3
Mergaert, L.4
Cleemput, I.5
-
4
-
-
75149175269
-
Les maladies orphelines et les médicaments orphelins: une analyse Belge et Européenne
-
Denis A., Mergaert L., Fostier C., Cleemput I., Simoens S. Les maladies orphelines et les médicaments orphelins: une analyse Belge et Européenne. Journal de Pharmacie de Belgique 2009, 4:131-137.
-
(2009)
Journal de Pharmacie de Belgique
, vol.4
, pp. 131-137
-
-
Denis, A.1
Mergaert, L.2
Fostier, C.3
Cleemput, I.4
Simoens, S.5
-
5
-
-
1642571450
-
-
Organisation for Economic Co-operation and Development, Paris, Organisation for Economic Co-operation and Development
-
Organisation for Economic Co-operation and Development Health at a glance 2007 2007, Organisation for Economic Co-operation and Development, Paris.
-
(2007)
Health at a glance 2007
-
-
-
6
-
-
77956178667
-
-
National Institute for Health and Disability Insurance, Brussels, National Institute for Health and Disability Insurance
-
National Institute for Health and Disability Insurance Pharmaceutical specialties 2009, National Institute for Health and Disability Insurance, Brussels.
-
(2009)
Pharmaceutical specialties
-
-
-
8
-
-
77956180279
-
Orphan drugs in Italy. Accommodating orphan drugs: balancing innovation and financial stability
-
Folino Gallo P. Orphan drugs in Italy. Accommodating orphan drugs: balancing innovation and financial stability. Presentation at the Office of Health Economics 2008.
-
(2008)
Presentation at the Office of Health Economics
-
-
Folino Gallo, P.1
-
10
-
-
77956181250
-
-
Dental and Pharmaceutical Benefits Agency
-
Dental and Pharmaceutical Benefits Agency Medicinal products database 2009, http://www.tlv.se/in-english.
-
(2009)
Medicinal products database
-
-
-
11
-
-
34447263989
-
-
National Institute for Health and Clinical Excellence
-
National Institute for Health and Clinical Excellence Appraising orphan drugs 2006, http://www.nice.org.uk/niceMedia/pdf/smt/120705item4.pdf.
-
(2006)
Appraising orphan drugs
-
-
-
12
-
-
66349107417
-
Evidence and values: requirements for public reimbursement of medicines for rare diseases-a case study in oncology
-
Drummond M., Evans B., LeLorier J., Karakiewicz P., Martin D., Tugwell P., et al. Evidence and values: requirements for public reimbursement of medicines for rare diseases-a case study in oncology. Canadian Journal of Clinical Pharmacology 2009, 16:e273-e281.
-
(2009)
Canadian Journal of Clinical Pharmacology
, vol.16
-
-
Drummond, M.1
Evans, B.2
LeLorier, J.3
Karakiewicz, P.4
Martin, D.5
Tugwell, P.6
-
13
-
-
3542998742
-
National Institute for Clinical Excellence and its value judgments
-
Rawlins M.D., Culyer A.J. National Institute for Clinical Excellence and its value judgments. British Medical Journal 2004, 329:224-227.
-
(2004)
British Medical Journal
, vol.329
, pp. 224-227
-
-
Rawlins, M.D.1
Culyer, A.J.2
-
14
-
-
38149110959
-
-
Scottish Medicines Consortium
-
Scottish Medicines Consortium Orphan drugs 2007, http://www.scottishmedicines.org.uk/smc/3869.html.
-
(2007)
Orphan drugs
-
-
-
18
-
-
31544452135
-
Is the current approach to reviewing new medicines condemning the victims of rare diseases to death? A call for a national orphan medicine review policy
-
Clarke J. Is the current approach to reviewing new medicines condemning the victims of rare diseases to death? A call for a national orphan medicine review policy. Canadian Medical Association Journal 2006, 174:189-190.
-
(2006)
Canadian Medical Association Journal
, vol.174
, pp. 189-190
-
-
Clarke, J.1
|